While malnutrition-inflammation syndrome may play a central role in poor clinical outcome, including a high rate of mortality, diminished quality of life and hospitalization, it may also lead to high level of ferritin and refractory anemia including unresponsiveness to EPO in these patients (6-8). The gene discussed is EPO; the disease is anemia (phenotype).